Helius Medical Technologies - Home

SIGNUP FOR NEWSLETTER

TSX: HSM     NASDAQ: HSDT

Call us: +1 877-564-0008

Menu

Stock Quote - HSM-T

*Delayed quote courtesy of Google.

Stock Quote - HSDT

*Delayed quote courtesy of Google.

2021 News

Filters
List of articles in category 2021 News
Title Date
Helius Medical Technologies, Inc. Expands Executive Leadership Team with the Appointment of Dane C. Andreeff as President and Chief Executive Officer and Jeffrey S. Mathiesen as Chief Financial Officer 15 Jun, 2021
Helius Medical Technologies, Inc. to Participate in Noble Capital Markets’ Virtual Road Show Series 08 Jun, 2021
Helius Medical Technologies, Inc. Appoints Frederick Fantazzia as Vice President of Sales & Marketing, North America 02 Jun, 2021
Helius Medical Technologies, Inc. Reports First Quarter 2021 Financial Results 17 May, 2021
Helius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21st 15 Apr, 2021
Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021 07 Apr, 2021
Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS™ Device 29 Mar, 2021
Helius Medical Technologies, Inc. to Present at the Investor Summit Group’s Q1 Virtual Summit on March 23rd 17 Mar, 2021
Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors 17 Mar, 2021
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results 10 Mar, 2021
Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021 02 Feb, 2021
Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option 01 Feb, 2021
Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market 28 Jan, 2021
Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services’ Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices 20 Jan, 2021
Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards 19 Jan, 2021
Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference 15 Jan, 2021
Helius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS™ Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis 11 Jan, 2021
Helius Medical Technologies, Inc. Comments on Unusual Market Activity 05 Jan, 2021
Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January 04 Jan, 2021